JP5914246B2 - Method for purifying brinzolamide - Google Patents
Method for purifying brinzolamide Download PDFInfo
- Publication number
- JP5914246B2 JP5914246B2 JP2012177972A JP2012177972A JP5914246B2 JP 5914246 B2 JP5914246 B2 JP 5914246B2 JP 2012177972 A JP2012177972 A JP 2012177972A JP 2012177972 A JP2012177972 A JP 2012177972A JP 5914246 B2 JP5914246 B2 JP 5914246B2
- Authority
- JP
- Japan
- Prior art keywords
- brinzolamide
- solution
- crystals
- purity
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Description
本発明は、緑内障治療薬として有用なブリンゾラミド(化学名:(R)−3,4−ジヒドロ−4−エチルアミノ−2−(3−メトキシプロピル)−2H−チエノ[3,2−e]−1,2−チアジン−6−スルホンアミド−1,1−ジオキシド)の新規な製造方法に関する。 The present invention relates to brinzolamide (chemical name: (R) -3,4-dihydro-4-ethylamino-2- (3-methoxypropyl) -2H-thieno [3,2-e]-useful as a glaucoma therapeutic agent. 1,2-thiazine-6-sulfonamido-1,1-dioxide).
下記式(1) Following formula (1)
で示されるブリンゾラミドは炭酸脱水素酵素阻害作用を持つ緑内障治療薬として用いられている。該ブリンゾラミドの製造方法としては、下記式(2) Is used as a therapeutic agent for glaucoma having a carbonic acid dehydrogenase inhibitory action. As a manufacturing method of this brinzolamide, following formula (2)
で示される(S)−3,4−ジヒドロ−4−ヒドロキシ−2−(3−メトキシプロピル)−2H−チエノ[3,2−e]−1,2−チアジン−6−スルホンアミド−1,1−ジオキシド(以下、スルホンアミド体とも言う。)より製造する方法が一般的に知られている。 (S) -3,4-dihydro-4-hydroxy-2- (3-methoxypropyl) -2H-thieno [3,2-e] -1,2-thiazine-6-sulfonamide-1, A method of producing from 1-dioxide (hereinafter also referred to as a sulfonamide) is generally known.
即ち、スルホンアミド体の6位置の炭素原子{以下、C(6)と略記する。}に結合したスルホンアミド官能基を保護してイミダート体とし(段階1)、イミダート体の4位置の炭素原子{以下、C(4)と略記する。}に結合した水酸基を活性化した後(段階2)、活性化したC(4)部位の水酸基をアミンでの置換、及びC(6)部位のスルホンアミド官能基から保護基を除去してブリンゾラミドを得る(段階3)、という方法が一般的に知られている(特許文献1および非特許文献1)。上記方法において、段階1の反応は、スルホンアミド体及び過剰のオルト酢酸トリメチル等のオルト酢酸低級アルキルのアセトニトリル溶液を12〜48時間還流することにより行われる。また、段階2の活性化は、溶媒を除去した後、溶媒をテトラヒドロフランに置き換え、段階1で得られたイミダート体をピリジン、トリエチルアミンまたはジメチルアミノピリジン等の塩基の存在下に無水メタンスルホン酸または塩化p−トルエンスルホニル、塩化p−ブロモトルエンスルホニル若しくは塩化p−ニトロトルエンスルホニル等の塩化スルホニルと反応させることによって行われるものであり、好ましくは、−10〜15℃の温度で1〜4時間、2.0〜2.5当量の塩化p−トルエンスルホニル及びトリエチルアミンを用いて行われる。さらに、段階3では、10〜40当量の適切なアミンを冷溶液に添加して8〜60時間反応させた後、生成物を酸−塩基処理することによってブリンゾラミドを単離していた。 That is, the carbon atom at the 6-position of the sulfonamide {hereinafter abbreviated as C (6). } Is protected to form an imidate (step 1), and the carbon atom at the 4-position of the imidate (hereinafter abbreviated as C (4)). } Is activated (step 2), the activated hydroxyl group at the C (4) site is replaced with an amine, and the protecting group is removed from the sulfonamide functional group at the C (6) site to form brinzolamide Is generally known (Step 3) (Patent Document 1 and Non-Patent Document 1). In the above method, the reaction in Step 1 is performed by refluxing a sulfonamide compound and an acetonitrile solution of lower alkyl orthoacetate such as excess trimethyl orthoacetate for 12 to 48 hours. In the activation of Step 2, after removing the solvent, the solvent is replaced with tetrahydrofuran, and the imidate obtained in Step 1 is converted to methanesulfonic anhydride or chloride in the presence of a base such as pyridine, triethylamine or dimethylaminopyridine. 1. It is carried out by reacting with sulfonyl chloride such as p-toluenesulfonyl, p-bromotoluenesulfonyl chloride or p-nitrotoluenesulfonyl chloride, and preferably at a temperature of −10 to 15 ° C. for 1 to 4 hours. 0-2.5 equivalents of p-toluenesulfonyl chloride and triethylamine are used. Further, in Step 3, the brinzolamide was isolated by acid-base treatment of the product after adding 10-40 equivalents of the appropriate amine to the cold solution and reacting for 8-60 hours.
一方、原薬として使用されるブリンゾラミドには、通常、純度が99.5%以上であり、融点が131℃付近であることが求められている。そのため、上記方法にて得られたブリンゾラミド粗体は、高純度に精製される必要がある。特許文献1および非特許文献1には、単離されたブリンゾラミド粗体を2−プロパノールから結晶化させることによって精製する方法が記載されているが、該方法では、得られるブリンゾラミド結晶の純度は97.4%であり(非特許文献1)、融点は125〜127℃であり(特許文献1)、満足のいくものではなかった。 On the other hand, brinzolamide used as a drug substance is usually required to have a purity of 99.5% or more and a melting point of around 131 ° C. Therefore, the brinzolamide crude body obtained by the above method needs to be purified with high purity. Patent Document 1 and Non-Patent Document 1 describe a method of purifying an isolated brinzolamide crude product by crystallization from 2-propanol. In this method, the purity of the obtained brinzolamide crystal is 97. .4% (Non-patent Document 1), and the melting point was 125 to 127 ° C. (Patent Document 1), which was not satisfactory.
また、他の精製方法として、特許文献2には、エタノールから再結晶させる方法が記載されている。しかしながら、本発明者らが検討したところ、エタノールから再結晶させる方法では、純度が99.5%以上のブリンゾラミド結晶が得られたが、その融点は125〜127℃であり、やはり満足のいくものは得られなかった。 As another purification method, Patent Document 2 describes a method of recrystallization from ethanol. However, as a result of studies by the present inventors, a method of recrystallization from ethanol yielded a brinzolamide crystal having a purity of 99.5% or more, but its melting point was 125 to 127 ° C., which was also satisfactory. Was not obtained.
このようにして得られた融点が125〜127℃を示すブリンゾラミド結晶は、融点が約131℃であるブリンゾラミド結晶と同じ結晶形を示すため、融点が低く測定されるのはブリンゾラミド結晶に含まれる不純物の影響があると考えられる。なお、上記方法にて得られたブリンゾラミド結晶の純度は99.5%以上と高いものではあるが、該純度の測定は液体クロマトグラフィーによるものであり、融点が低いという結果から考えると、このような純度測定方法では検出されない不純物が含まれていることが考えられた。 The thus obtained brinzolamide crystal having a melting point of 125 to 127 ° C. shows the same crystal form as that of the brinzolamide crystal having a melting point of about 131 ° C. Therefore, it is the impurity contained in the brinzolamide crystal that has a low melting point. It is thought that there is an influence. Although the purity of the brinzolamide crystals obtained by the above method is as high as 99.5% or higher, the measurement of the purity is based on liquid chromatography. It was considered that impurities that could not be detected by a simple purity measurement method were included.
したがって、本発明の目的は、高純度のブリンゾラミドを製造する方法を提供することにある。 Accordingly, it is an object of the present invention to provide a method for producing high purity brinzolamide.
本発明者らは、前記課題を解決するために鋭意検討した。その結果、ブリンゾラミドの粗体をエタノールから再結晶させる方法において、再結晶操作の前に活性炭処理を実施し、さらに結晶化させる際に種晶を加えることによって、効率的に不純物を除去することができることを見出した。
即ち、本発明は、(R)−3,4−ジヒドロ−4−エチルアミノ−2−(3−メトキシプロピル)−2H−チエノ[3,2−e]−1,2−チアジン−6−スルホンアミド−1,1−ジオキシド(ブリンゾラミド)の粗体とエタノールとを混合し、当該粗体のエタノール溶液からなる第一溶液を調整する工程、前記第一溶液と活性炭とを、液温60〜80℃に保ちながら混合した後に活性炭を分離して第二溶液を得る活性炭処理工程、前記第二溶液から種晶を用いて(R)−3,4−ジヒドロ−4−エチルアミノ−2−(3−メトキシプロピル)−2H−チエノ[3,2−e]−1,2−チアジン−6−スルホンアミド−1,1−ジオキシド(ブリンゾラミド)の結晶を析出させる結晶化工程を含んでなることを特徴とする方法である。
また、本発明において、上記結晶化工程は2〜4回行うことが好ましく、上記再結晶操作において、45〜55℃にて種晶を加えることが好ましい。
The present inventors diligently studied to solve the above problems. As a result, in the method of recrystallizing brinzolamide from ethanol, impurities can be efficiently removed by performing activated carbon treatment before recrystallization operation and adding seed crystals during further crystallization. I found out that I can do it.
That is, the present invention relates to (R) -3,4-dihydro-4-ethylamino-2- (3-methoxypropyl) -2H-thieno [3,2-e] -1,2-thiazine-6-sulfone. A step of mixing a crude product of amide-1,1-dioxide (brinzolamide) and ethanol to prepare a first solution comprising the ethanol solution of the crude product, the first solution and activated carbon having a liquid temperature of 60 to 80 Activated carbon treatment step of separating activated carbon after mixing while maintaining at ° C. to obtain a second solution, (R) -3,4-dihydro-4-ethylamino-2- (3) using seed crystals from the second solution -Methoxypropyl) -2H-thieno [3,2-e] -1,2-thiazine-6-sulfonamido-1,1-dioxide (brinzolamide) crystallizing step is included. It is a method.
Moreover, in this invention, it is preferable to perform the said crystallization process 2-4 times, and it is preferable to add a seed crystal at 45-55 degreeC in the said recrystallization operation.
本発明によれば、ブリンゾラミドの粗体を特定の方法で精製することによって、融点が約131℃で、純度が99.6%以上、さらには99.8%以上の高純度のブリンゾラミド結晶を安定的に製造することができる。 According to the present invention, by purifying a brinzolamide crude product by a specific method, a high-purity brinzolamide crystal having a melting point of about 131 ° C. and a purity of 99.6% or more, more preferably 99.8% or more is stabilized. Can be manufactured automatically.
本発明は、ブリンゾラミドの粗体とエタノールとを混合し、当該粗体のエタノール溶液からなる第一溶液を調整する工程、前記第一溶液と活性炭とを、液温を60〜80℃に保ちながら混合した後に活性炭を分離して第二溶液を得る活性炭処理工程、前記第二溶液から種晶を用いてブリンゾラミドの結晶を析出させる結晶化工程を含んでなることを特徴とする方法である。
以下、本発明の詳細について、順を追って説明する。
The present invention is a step of mixing a brinzolamide crude and ethanol to prepare a first solution comprising the crude ethanol solution, while maintaining the liquid temperature at 60 to 80 ° C. An activated carbon treatment step of separating activated carbon after mixing to obtain a second solution, and a crystallization step of precipitating brinzolamide crystals from the second solution using seed crystals.
Hereinafter, details of the present invention will be described in order.
(ブリンゾラミド粗体)
本発明で使用するブリンゾラミド粗体は、特に制限されるものではなく、公知の方法、例えば特許文献1に記載の方法で製造されたものが使用され、下記製造方法で製造されたものを使用することもできる。下記製造方法では純度が97〜99%のブリンゾラミドを安定して得ることができ、これを本発明のブリンゾラミド粗体として使用することによって、より高純度のブリンゾラミド結晶を安定して製造することができる。以下、該製造方法の詳細を説明する。
(Brinzolamide crude)
The brinzolamide crude product used in the present invention is not particularly limited, and a known method, for example, one produced by the method described in Patent Document 1 is used, and one produced by the following production method is used. You can also. In the following production method, a brinzolamide having a purity of 97 to 99% can be stably obtained, and by using this as a crude brinzolamide of the present invention, a higher-purity brinzolamide crystal can be stably produced. . Details of the production method will be described below.
(ブリンゾラミド粗体の製造方法)
該製造方法において、ブリンゾラミド粗体は、前記スルホンアミド体から、反応工程、分離工程、単離工程を経て製造される。以下、各工程の詳細を説明する。
(Method for producing brinzolamide crude product)
In the production method, the brinzolamide crude product is produced from the sulfonamide product through a reaction step, a separation step, and an isolation step. Hereinafter, details of each process will be described.
1.反応工程
反応工程では、前記スルホンアミド体のC(4)部位に結合した水酸基を活性化した後エチルアミノ化して前記目的物を含む反応混合物を得る。すなわち、原料化合物のC(4)部位に結合した水酸基を活性化する活性化工程、活性化された水酸基をエチルアミンで置換して、目的化合物を生成するアミノ化工程を含んでなる方法により好適に行うことができる。また、必要に応じて活性化工程前に原料化合物のC(6)部位に結合したスルホンアミド基を保護して、保護された原料化合を生成する保護工程を行っても良い。保護工程を行った場合、活性化工程実施後、アミノ化工程の前後いずれかに脱保護工程を入れても良い。
1. Reaction Step In the reaction step, the hydroxyl group bonded to the C (4) site of the sulfonamide is activated and then ethylaminated to obtain a reaction mixture containing the target product. That is, the method preferably comprises an activation step of activating the hydroxyl group bonded to the C (4) site of the starting compound, and an amination step of generating the target compound by substituting the activated hydroxyl group with ethylamine. It can be carried out. Moreover, you may perform the protection process which protects the sulfonamide group couple | bonded with C (6) site | part of the raw material compound and produces | generates the protected raw material compound before an activation process as needed. When a protection process is performed, a deprotection process may be performed either before or after the amination process after the activation process.
上記保護工程における、前記原料化合物のC(6)部位に結合したスルホンアミド基の保護は、反応溶媒中で原料化合物と保護剤としてのオルト酢酸低級アルキルを加熱混合することにより好適に行うことができる。オルト酢酸低級アルキルとしては、反応で副生するアルコールの除去が容易であるという理由からオルト酢酸トリメチルを使用することが特に好ましい。また、反応溶媒は反応に関与しない不活性溶媒であれば特に制限されないが、反応温度の管理が容易であることから、酢酸エチル、アセトニトリルを用いるのが特に好ましい。反応条件は適宜決定すればよいが、通常、原料化合物、当該原料化合物1モルに対して1.0〜1.5モルのオルト酢酸低級アルキル、及び原料化合物1質量部に対して1.5〜10質量部の反応溶媒を混合し、還流下1〜24時反応させればよい。このような反応を行うことにより、C(6)部位に結合したスルホンアミド基が保護された原料化合物(以下、イミダート体とも言う。)を得ることができる。 In the protection step, protection of the sulfonamide group bonded to the C (6) site of the raw material compound is preferably performed by heating and mixing the raw material compound and a lower alkyl orthoacetate as a protective agent in a reaction solvent. it can. As the lower alkyl orthoacetate, trimethyl orthoacetate is particularly preferably used because the alcohol produced as a by-product in the reaction can be easily removed. The reaction solvent is not particularly limited as long as it is an inert solvent that does not participate in the reaction. However, it is particularly preferable to use ethyl acetate or acetonitrile because the reaction temperature can be easily controlled. The reaction conditions may be appropriately determined. Usually, the raw material compound, 1.0 to 1.5 moles of lower alkyl orthoacetate with respect to 1 mole of the raw material compound, and 1.5 to 1.5 parts with respect to 1 part by weight of the raw material compound. What is necessary is just to mix 10 mass parts reaction solvent and to make it react for 1 to 24 hours under recirculation | reflux. By performing such a reaction, a raw material compound in which the sulfonamide group bonded to the C (6) site is protected (hereinafter also referred to as imidate) can be obtained.
上記活性化工程における水酸基の活性化は、例えば、上記保護工程終了後、溶媒を留去することによりイミダート体の濃縮物を得、これをテトラヒドロフラン等の有機溶媒に溶解させて得た溶液を冷却してから当該溶液にイミダート体1モルに対して1.0〜1.5モルの塩化スルホニル化合物を添加し、−10〜15℃の温度で1〜4時間攪拌することによって行うことができる。このような操作により、C(4)部位がスルホニル化された原料化合物またはイミダート体(以下、スルホニル体とも言う。)を得ることができる。該化合物は反応液中に溶解しているので、アミノ化反応は該反応液にエチルアミンを加えることにより行うことができる。なお、塩化スルホニル化合物としては、引き続き行う脱離工程における反応時間が短縮でき、収率も向上するという理由から、塩化p−トルエンスルホニルを使用することが好ましい。 The activation of the hydroxyl group in the activation step is, for example, obtaining an imidate concentrate by distilling off the solvent after completion of the protection step, and cooling the solution obtained by dissolving the concentrate in an organic solvent such as tetrahydrofuran. Then, 1.0 to 1.5 mol of a sulfonyl chloride compound is added to the solution with respect to 1 mol of the imidate, and the mixture is stirred at a temperature of −10 to 15 ° C. for 1 to 4 hours. By such an operation, a raw material compound or imidate body (hereinafter also referred to as a sulfonyl body) in which the C (4) moiety is sulfonylated can be obtained. Since the compound is dissolved in the reaction solution, the amination reaction can be performed by adding ethylamine to the reaction solution. As the sulfonyl chloride compound, it is preferable to use p-toluenesulfonyl chloride because the reaction time in the subsequent desorption step can be shortened and the yield is improved.
脱保護工程における脱保護反応は活性化工程後ならば、アミノ化工程の前後どちらに実施しても良い。活性化基が脱保護材の影響を受けることがないことからアミノ化工程と同時またはアミノ化工程の後の実施した方が良い。脱保護の方法はオルト酢酸低級アルキルを脱保護する一般的な方法ならいかなる反応でも良いが、後述のエチル化反応と同時に実施できることから70%エチルアミン水溶液中の水を用いるのが特に好ましい。 The deprotection reaction in the deprotection step may be performed either before or after the amination step as long as it is after the activation step. Since the activating group is not affected by the deprotecting material, it is better to carry out at the same time as the amination step or after the amination step. The deprotection method may be any reaction as long as it is a general method for deprotecting lower alkyl orthoacetate, but it is particularly preferable to use water in a 70% ethylamine aqueous solution because it can be carried out simultaneously with the ethylation reaction described later.
前記アミノ化工程はスルホニル体とエチルアミンを反応させることから成る。用いるエチルアミンはどのような形態でも良いが、入手の容易さ、前述の脱保護工程をアミノ化と同時に実施できること、エチルアミンの濃度が高く反応効率が高いことから70%エチルアミン水溶液を用いるのが特に良い。スルホニル体とエチルアミンとの反応(アミノ化反応)は10℃以下に冷却された反応液にエチルアミンをスルホニル体1モルに対するエチルアミンの量が10〜50モルとなるように添加し、冷却を維持したまま、所定時間反応させることによって好適に行うことができる。反応温度は10℃以下ならば特に問題無いが、低温では反応純度が向上することから5℃以下が良い。温度が低下すると全体の反応速度も低下することから0℃〜5℃が特に良い。冷却は反応進行度が90%以上まで行うのが特に良いが、必要に応じて反応進行度に応じて加温しても良い。但し、10℃以上まで加熱する際の反応進行度が低い場合、得られる目的化合物の収量、純度の向上幅は小さくなる。なお、この場合反応進行度は目的化合物と保護化された目的化合物の合計を目的化合物、保護化された目的化合物、スルホニル体、脱保護化されたスルホニル体の合計で除したものをいう。 The amination step comprises reacting a sulfonyl compound with ethylamine. Any form of ethylamine may be used, but it is particularly preferable to use a 70% aqueous solution of ethylamine because it is readily available, the deprotection step described above can be performed simultaneously with the amination, and the concentration of ethylamine is high and the reaction efficiency is high. . In the reaction (amination reaction) between the sulfonyl compound and ethylamine, ethylamine was added to the reaction solution cooled to 10 ° C. or less so that the amount of ethylamine was 10 to 50 mol relative to 1 mol of the sulfonyl compound, and the cooling was maintained. The reaction can be suitably carried out by reacting for a predetermined time. There is no particular problem if the reaction temperature is 10 ° C. or lower, but 5 ° C. or lower is preferable because the reaction purity improves at low temperatures. Since the whole reaction rate also falls when temperature falls, 0 to 5 degreeC is especially good. The cooling is particularly preferably performed until the reaction progress is 90% or more, but may be heated according to the reaction progress as necessary. However, when the reaction progress at the time of heating to 10 ° C. or higher is low, the range of improvement in the yield and purity of the target compound obtained is small. In this case, the degree of reaction progress refers to the sum of the target compound and the protected target compound divided by the total of the target compound, the protected target compound, the sulfonyl compound, and the deprotected sulfonyl compound.
2.分離工程
分離工程では、前記工程で得られた反応混合物から前記目的化合物の粗体を分離する。ここでいう分離とは、反応混合物中の反応溶媒および水溶性不純物と、有機系不純物を含む目的化合物からなる粗体とを分離することを意味する。また、目的化合物の粗体とは、主たる不純物として有機系不純物(有機系副生物や残存有機溶媒など)を含む目的化合物を意味し、通常も目的化合物の純度が65〜85%程度の固体状若しくは粘稠な液状のものを意味する。反応混合物からの粗体の分離は、反応混合物である反応溶液に炭酸水素ナトリウムなどの塩基を添加して中和した後に、酢酸エチルなどの有機溶媒(抽出溶媒)を用いて有機成分を分離し、必要に応じて水洗、乾燥(水分除去)を行い、抽出溶媒を留去して濃縮することにより好適に行うことができる。
2. Separation step In the separation step, the crude product of the target compound is separated from the reaction mixture obtained in the step. Separation here means separating the reaction solvent and water-soluble impurities in the reaction mixture from the crude product comprising the target compound containing organic impurities. The crude product of the target compound means a target compound containing organic impurities (such as organic by-products and residual organic solvents) as main impurities, and is usually a solid having a purity of about 65 to 85%. Or it means a viscous liquid. Separation of the crude product from the reaction mixture is accomplished by adding a base such as sodium hydrogen carbonate to the reaction solution, which is the reaction mixture, and then separating the organic components using an organic solvent (extraction solvent) such as ethyl acetate. If necessary, washing with water and drying (moisture removal) are performed, and the extraction solvent is distilled off and concentrated.
3.単離工程
単離工程では、得られた目的化合物を有機溶媒へ溶解させ該当混合溶液から目的化合物を結晶化させる。用いる溶媒は単一溶媒でも混合溶媒でも良いが、アルコールと非極性溶媒の混合溶液、またはアルコールが良い。得られる目的化合物の純度、収率が高くなることから2−プロパノールが特に好ましい。このとき使用する溶媒量は、通常、粗体1質量部に対して1〜50質量部である。バッチ収量及びろ過工程の操作性向上を考慮すると2〜10質量部が好ましい。このようにして調製された溶液から目的化合物を結晶化させるには、溶液を冷却すればよい。なお、溶液を調製する際の温度にもよるが、アルコールに粗体を溶解させてから非極性溶媒を添加する場合には、非極性溶媒の添加に伴い目的物の結晶化が起ることもある。通常は、粗体を含む溶液を50℃〜100℃に加熱して粗体を完全に溶解せしめてから溶液を−10℃〜20℃に冷却して結晶化を行うことが好ましい。
3. Isolation Step In the isolation step, the obtained target compound is dissolved in an organic solvent, and the target compound is crystallized from the corresponding mixed solution. The solvent to be used may be a single solvent or a mixed solvent, but a mixed solution of alcohol and a nonpolar solvent, or alcohol is preferable. 2-Propanol is particularly preferable because the purity and yield of the target compound obtained are high. The amount of solvent used at this time is usually 1 to 50 parts by mass with respect to 1 part by mass of the coarse body. Considering the batch yield and the operability improvement of the filtration step, 2 to 10 parts by mass is preferable. In order to crystallize the target compound from the solution thus prepared, the solution may be cooled. Depending on the temperature at which the solution is prepared, when the nonpolar solvent is added after the crude product is dissolved in alcohol, the target product may crystallize with the addition of the nonpolar solvent. is there. Usually, it is preferable to perform crystallization by heating the solution containing the crude product to 50 ° C. to 100 ° C. to completely dissolve the crude product and then cooling the solution to −10 ° C. to 20 ° C.
本発明では、上記ブリンゾラミド粗体に本発明の操作を実施することによって、高純度のブリンゾラミド結晶を製造することが出来る。すなわち、本発明は、ブリンゾラミド粗体とエタノールとを混合し、当該粗体のエタノール溶液からなる第一溶液を調整する工程、前記第一溶液と活性炭とを、液温を60〜80℃に保ちながら混合した後に活性炭を分離して第二溶液を得る活性炭処理工程、前記第二溶液から種晶を用いてブリンゾラミドの結晶を析出させる結晶化工程を含んでなることを特徴とする方法である。以下、本発明の各操作の詳細について説明する。 In the present invention, a high-purity brinzolamide crystal can be produced by performing the operation of the present invention on the brinzolamide crude product. That is, the present invention comprises a step of mixing a brinzolamide crude body and ethanol to prepare a first solution comprising the crude ethanol solution, and maintaining the liquid temperature at 60 to 80 ° C. The activated carbon treatment step of separating the activated carbon after mixing to obtain a second solution, and the crystallization step of precipitating brinzolamide crystals from the second solution using seed crystals. Hereinafter, details of each operation of the present invention will be described.
(第一溶液調整工程)
本発明では、まず、ブリンゾラミド粗体とエタノールとを混合し、当該粗体のエタノール溶液からなる第一溶液を調整する。
本発明において、上記第一溶液を調整する方法は特に限定されず、具体的には、ブリンゾラミド粗体とエタノールとを混合し、必要に応じて加熱することによって、当該粗体を溶解させて上記第一溶液を得ることができる。加熱する際の温度は、当該粗体が溶解する温度であれば特に限定されないが、60〜80℃とすることによって、次の活性炭処理工程をそのまま行うことができるため好ましい。
また、本発明で溶媒として使用されるエタノールの量は、精製能力、操作性等を考慮すると、ブリンゾラミド粗体1質量部に対して、4〜16質量部であることが好ましく、8〜12質量部であることがより好ましい。
(First solution adjustment process)
In the present invention, first, a brinzolamide crude product and ethanol are mixed to prepare a first solution composed of an ethanol solution of the crude product.
In the present invention, the method for preparing the first solution is not particularly limited. Specifically, the brinzolamide crude body and ethanol are mixed and heated as necessary to dissolve the crude body and A first solution can be obtained. Although the temperature at the time of heating will not be specifically limited if it is the temperature which the said rough body melt | dissolves, Since the next activated carbon treatment process can be performed as it is, it is preferable.
In addition, the amount of ethanol used as a solvent in the present invention is preferably 4 to 16 parts by mass, and 8 to 12 parts by mass with respect to 1 part by mass of the brinzolamide crude material in consideration of purification ability, operability and the like. More preferably, it is a part.
(活性炭処理工程)
本発明の活性炭処理工程は、前記第一溶液と活性炭とを、液温を60〜80℃に保ちながら混合した後に活性炭を分離して第二溶液を得る工程である。本発明において、下記結晶化工程の前に当該工程を実施することによって、下記結晶化工程では除去されない不純物が効果的に除去され、さらに下記結晶化工程で種晶を使用することによって、融点が131℃で高純度のブリンゾラミド結晶を得ることができる。
本発明の活性炭処理工程では、具体的には、前記第一溶液と活性炭とを混合し、この混合液を熱時濾過することによって活性炭を除去して第二溶液を得る。当該工程においては、混合液を撹拌することが好ましい。また、除去された活性炭を70〜80℃のエタノールで洗浄し、得られた洗浄液を、熱時濾過で得られた濾液とあわせて第二溶液とすることが好ましい。
(Activated carbon treatment process)
The activated carbon treatment step of the present invention is a step of obtaining the second solution by separating the activated carbon after mixing the first solution and activated carbon while maintaining the liquid temperature at 60 to 80 ° C. In the present invention, by performing this step before the following crystallization step, impurities that are not removed in the following crystallization step are effectively removed, and by using seed crystals in the following crystallization step, the melting point is reduced. High purity brinzolamide crystals can be obtained at 131 ° C.
In the activated carbon treatment step of the present invention, specifically, the first solution and activated carbon are mixed, and the mixed solution is filtered while hot to remove the activated carbon to obtain a second solution. In this step, it is preferable to stir the mixed solution. Moreover, it is preferable to wash | clean the removed activated carbon with 70-80 degreeC ethanol, and to make the obtained washing | cleaning liquid into a 2nd solution with the filtrate obtained by hot filtration.
当該活性炭処理工程において使用される活性炭の量は、活性炭処理により向上する純度および、それに続く結晶化での純度向上度、操作性、さらには副次的に得られる脱色効果等を考慮すると、ブリンゾラミド粗体1質量部に対して、0.05〜0.5質量部であることが好ましく、0.1〜0.3重量部であることがより好ましい。また、当該工程において、洗浄で使用するエタノールの量は1〜4質量部であることが好ましい。
さらに、当該活性炭処理工程は、長時間実施することによってブリンゾラミドが分解する恐れがあることから、第一溶液と活性炭とを混合して、5分〜2時間撹拌することが好ましく、10〜20分間撹拌することがさらに好ましい。
当該活性炭処理工程で得られた第二溶液を用い、そのまま次の結晶化工程を行うことができる。
The amount of activated carbon used in the activated carbon treatment step is determined by considering the purity improved by the activated carbon treatment, the degree of purity improvement in the subsequent crystallization, the operability, and the secondary decolorization effect. It is preferable that it is 0.05-0.5 mass part with respect to 1 mass part of coarse bodies, and it is more preferable that it is 0.1-0.3 weight part. Moreover, in the said process, it is preferable that the quantity of ethanol used by washing | cleaning is 1-4 mass parts.
Furthermore, since the brinzolamide may be decomposed by carrying out the activated carbon treatment step for a long time, the first solution and the activated carbon are mixed and preferably stirred for 5 minutes to 2 hours, for 10 to 20 minutes. It is more preferable to stir.
Using the second solution obtained in the activated carbon treatment step, the next crystallization step can be performed as it is.
(結晶化工程)
本発明の結晶化工程は、前記第二溶液から種晶を用いてブリンゾラミドの結晶を析出させる工程である。
本発明の結晶化工程は、具体的には、前記第二溶液を45〜55℃まで冷却して種晶を添加し、ブリンゾラミドの結晶を析出させる。また、種晶を添加した後、混合液を攪拌しながら毎時6〜60℃、好ましくは毎時25〜35℃にて溶液の温度を下げ、0〜20℃さらに好ましくは0〜5℃で1時間以上保持して、結晶を析出させることが好ましい。この混合液を濾過してエタノールを除去し、得られた結晶を0〜25℃のエタノールで1〜3回洗浄し、ブリンゾラミド結晶を得ることができる。当該結晶化工程1回における収率は90〜95%となる。
当該結晶化工程で使用される種晶は、ブリンゾラミドの結晶であれば特に限定されず、使用される種晶の量は、ブリンゾラミド粗体1質量部に対して、0.0001〜0.001質量部であることが種晶の分散性等の点で好ましい。また、上記洗浄で使用されるエタノールの量は、0.8〜2質量部であることが好ましい。
また、本発明においては、当該結晶化工程を2〜4回行うことが好ましい。当該結晶工程を2回行うことによって、ブリンゾラミド結晶の純度を99.8%以上とすることができ、3〜4回行うことによって純度を99.9%以上とすることができる。
(Crystallization process)
The crystallization step of the present invention is a step of precipitating brinzolamide crystals from the second solution using seed crystals.
Specifically, in the crystallization step of the present invention, the second solution is cooled to 45 to 55 ° C., seed crystals are added, and crystals of brinzolamide are precipitated. Further, after adding the seed crystal, the temperature of the solution is lowered at 6 to 60 ° C./hour, preferably 25 to 35 ° C./hour while stirring the mixed solution, and 0 to 20 ° C., more preferably 0 to 5 ° C. for 1 hour. It is preferable to hold the above to precipitate crystals. This mixed solution is filtered to remove ethanol, and the obtained crystals are washed 1 to 3 times with ethanol at 0 to 25 ° C. to obtain brinzolamide crystals. The yield in one crystallization step is 90 to 95%.
The seed crystal used in the crystallization step is not particularly limited as long as it is a brinzolamide crystal, and the amount of the seed crystal used is 0.0001 to 0.001 mass relative to 1 part by mass of the brinzolamide crude body. Part is preferable from the viewpoint of dispersibility of the seed crystals. Moreover, it is preferable that the quantity of ethanol used by the said washing | cleaning is 0.8-2 mass parts.
Moreover, in this invention, it is preferable to perform the said crystallization process 2-4 times. By performing the crystallization process twice, the purity of the brinzolamide crystal can be increased to 99.8% or higher, and by performing the process three to four times, the purity can be increased to 99.9% or higher.
本発明において、2回目以降の結晶化工程では、前の結晶化工程で得られたブリンゾラミドの結晶とエタノールとを混合して第二溶液とし、前記第二溶液から種晶を用いてブリンゾラミドの結晶を析出させる。具体的には、前の結晶化工程で得られたブリンゾラミドの結晶とエタノールとを混合し、必要に応じて加熱して当該結晶のエタノール溶液からなる第二溶液とし、上記1回目の結晶化工程と同様の操作をすることによって結晶を析出させ、固液分離して結晶を得ることが好ましい。第二溶液を得る際に、加熱する場合の温度は、当該結晶が溶解する温度であれば特に限定されないが、種晶の添加温度である45〜55℃より高温であれば特に限定されず、当該結晶が溶解する温度であればよい。また、2回目以降の結晶化工程において、溶媒として使用されるエタノールの量は、収率,純度,操作性等を考慮すると、ブリンゾラミド1質量部に対してエタノール4〜16質量部であることが好ましく、8〜12質量部であることがより好ましい。 In the present invention, in the second and subsequent crystallization steps, the crystals of brinzolamide obtained in the previous crystallization step and ethanol are mixed to form a second solution, and the crystals of brinzolamide are obtained using seed crystals from the second solution. To precipitate. Specifically, the crystal of brinzolamide obtained in the previous crystallization step and ethanol are mixed and heated as necessary to form a second solution comprising the ethanol solution of the crystal, and the first crystallization step It is preferable to obtain crystals by precipitating crystals by the same operation as in, and solid-liquid separation. When obtaining the second solution, the temperature when heating is not particularly limited as long as the crystal is dissolved, but is not particularly limited as long as it is higher than the seed crystal addition temperature of 45 to 55 ° C. Any temperature at which the crystal dissolves may be used. Further, in the second and subsequent crystallization steps, the amount of ethanol used as a solvent is 4 to 16 parts by mass of ethanol with respect to 1 part by mass of brinzolamide in consideration of yield, purity, operability, and the like. Preferably, it is 8-12 mass parts.
本発明によれば、上記のとおり、活性炭処理操作に続いて、種晶を使用した再結晶操作を実施することによって、融点が約131℃で、純度が99.6%以上のブリンゾラミド結晶を安定的に製造することができる。さらに、再結晶操作を2〜4回行うことによって、得られるブリンゾラミド結晶の純度を99.8%以上、さらには99.9%以上とすることができる。 According to the present invention, as described above, by performing the recrystallization operation using the seed crystal following the activated carbon treatment operation, the brinzolamide crystal having a melting point of about 131 ° C. and a purity of 99.6% or more is stabilized. Can be manufactured automatically. Furthermore, by performing the recrystallization operation 2 to 4 times, the purity of the obtained brinzolamide crystal can be made 99.8% or more, and further 99.9% or more.
以下、実施例によって本発明をさらに詳細に説明するが、本発明はこれらの実施例に限定されるものではない。
なお、実施例、比較例で得られたブリンゾラミドの純度測定は、以下のように行った。
EXAMPLES Hereinafter, although an Example demonstrates this invention further in detail, this invention is not limited to these Examples.
In addition, the purity measurement of the brinzolamide obtained by the Example and the comparative example was performed as follows.
<ブリンゾラミドなどの純度の測定方法>
装置:WATERS社製 Alliance 型式e2695−2489
検出器:紫外吸光光度計(測定波長:254nm)
カラム:ジーエルサイエンス株式会社製 商品名 Inertsil CN−3、粒径5μm、内径4.6mm、長さ25cm、
カラム温度:40℃ 一定温度
移動相:n−ヘキサン/エタノール=80/20
流量:1.0ml/分
測定時間:45分
<Method for measuring purity of brinzolamide, etc.>
Apparatus: Alliance model e2695-2489 manufactured by WATERS
Detector: UV absorptiometer (measurement wavelength: 254 nm)
Column: GL Science Co., Ltd. product name Inertsil CN-3, particle size 5 μm, inner diameter 4.6 mm, length 25 cm,
Column temperature: 40 ° C. Constant temperature mobile phase: n-hexane / ethanol = 80/20
Flow rate: 1.0 ml / min Measurement time: 45 minutes
実施例1
ブリンゾラミド粗体(純度98.25%)1gにエタノール8gを加え70℃で加熱溶解して得られた第一溶液に、活性炭0.2g加え10分間攪拌した後、濾過操作によって活性炭を除去し、70℃のエタノール4gで活性炭を洗浄し、濾液と洗浄液を合わせて第二溶液を得た(活性炭処理工程)。第二溶液を攪拌しながら50℃まで徐冷し、種晶0.001gを添加した後、100分間で0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃のエタノール0.8gで2回洗浄し、ブリンゾラミド結晶0.9g(純度99.64%)を得た(結晶化工程1回目)。この結晶にエタノール10.7gを加え、70℃で加熱溶解した。溶液を攪拌しながら50℃まで徐冷し、種晶0.0009g添加した後100分間で0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃のエタノール0.71gで2回洗浄し、ブリンゾラミド結晶0.82g(純度99.88%)を得た(結晶化工程2回目)。この結晶にエタノール9.7gを加え、70℃で加熱溶解した。溶液を攪拌しながら50℃まで徐冷し、種晶0.0008g添加した後100分間で0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃のエタノール0.65gで2回洗浄し、乾燥後、ブリンゾラミド結晶0.75g(純度99.93%)を得た(結晶化工程3回目)。得られたブリンゾラミド結晶の融点は131℃であり、光学純度は100.0%ee.であった。
Example 1
To the first solution obtained by adding 8 g of ethanol to 1 g of brinzolamide crude body (purity 98.25%) and dissolving by heating at 70 ° C., 0.2 g of activated carbon was added and stirred for 10 minutes, and then the activated carbon was removed by filtration operation. The activated carbon was washed with 4 g of ethanol at 70 ° C., and the filtrate and the washing solution were combined to obtain a second solution (activated carbon treatment step). The second solution was gradually cooled to 50 ° C. while stirring, 0.001 g of seed crystals was added, and then cooled to 0 ° C. over 100 minutes and stirred for 1 hour. The precipitated crystals were obtained by filtration and washed twice with 0.8 g of ethanol at 0 ° C. to obtain 0.9 g of brinzolamide crystals (purity 99.64%) (first crystallization step). 10.7 g of ethanol was added to the crystals and dissolved by heating at 70 ° C. The solution was gradually cooled to 50 ° C. while stirring, 0.0009 g of seed crystals were added, and then cooled to 0 ° C. over 100 minutes and stirred for 1 hour. The precipitated crystals were obtained by filtration and washed twice with 0.71 g of ethanol at 0 ° C. to obtain 0.82 g of brinzolamide crystals (purity 99.88%) (the second crystallization step). 9.7 g of ethanol was added to the crystals and dissolved by heating at 70 ° C. The solution was gradually cooled to 50 ° C. with stirring, 0.0008 g of seed crystals were added, and then cooled to 0 ° C. over 100 minutes and stirred for 1 hour. Precipitated crystals were obtained by filtration, washed twice with 0.65 g of ethanol at 0 ° C. and dried to obtain 0.75 g of brinzolamide crystals (purity 99.93%) (the third crystallization step). The obtained brinzolamide crystal had a melting point of 131 ° C. and an optical purity of 100.0% ee. Met.
実施例2
ブリンゾラミド粗体(純度98.66%)38.02gにエタノール300gを加え70℃で加熱溶解して得られた第一溶液に、活性炭7.6g加え10分間攪拌した後、濾過操作によって活性炭を除去し、70℃のエタノール150gで活性炭を洗浄し、濾液と洗浄液を合わせて第二溶液を得た(活性炭処理工程)。第二溶液を攪拌しながら50℃まで徐冷し、種晶0.038gを添加した後、100分間で0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃のエタノール30gで2回洗浄し、ブリンゾラミド結晶34.2g(純度99.68%)を得た(結晶化工程1回目)。この結晶にエタノール405gを加え、70℃で加熱溶解した。溶液を攪拌しながら50℃まで徐冷し、種晶0.034g添加した後100分間で0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃のエタノール27gで2回洗浄し、ブリンゾラミド結晶31.5g(純度99.81%)を得た(結晶化工程2回目)。この結晶にエタノール249gを加え、70℃で加熱溶解した。溶液を攪拌しながら50℃まで徐冷し、種晶0.031g添加した後100分間で0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃のエタノール25gで2回洗浄し、乾燥後、ブリンゾラミド結晶29.0g(純度99.95%)を得た(結晶化工程3回目)。得られたブリンゾラミド結晶の融点は131℃であり、光学純度は100.0%ee.であった。
Example 2
After adding 7.6 g of activated carbon to the first solution obtained by adding ethanol 300 g to 38.02 g of brinzolamide crude (purity 98.66%) at 70 ° C. and stirring for 10 minutes, the activated carbon was removed by filtration. The activated carbon was washed with 150 g of ethanol at 70 ° C., and the filtrate and the washing solution were combined to obtain a second solution (activated carbon treatment step). The second solution was gradually cooled to 50 ° C. while stirring, 0.038 g of seed crystals were added, and then cooled to 0 ° C. over 100 minutes and stirred for 1 hour. The precipitated crystals were obtained by filtration and washed twice with 30 g of ethanol at 0 ° C. to obtain 34.2 g of brinzolamide crystals (purity 99.68%) (first crystallization step). 405 g of ethanol was added to the crystals and dissolved by heating at 70 ° C. The solution was gradually cooled to 50 ° C. while stirring, 0.034 g of seed crystals were added, and then cooled to 0 ° C. over 100 minutes and stirred for 1 hour. Precipitated crystals were obtained by filtration and washed twice with 27 g of ethanol at 0 ° C. to obtain 31.5 g of brinzolamide crystals (purity 99.81%) (second crystallization step). To this crystal, 249 g of ethanol was added and dissolved by heating at 70 ° C. The solution was gradually cooled to 50 ° C. with stirring, 0.031 g of seed crystals were added, and then cooled to 0 ° C. over 100 minutes and stirred for 1 hour. Precipitated crystals were obtained by filtration, washed twice with 25 g of ethanol at 0 ° C., and dried to obtain 29.0 g of brinzolamide crystals (purity 99.95%) (the third crystallization step). The obtained brinzolamide crystal had a melting point of 131 ° C. and an optical purity of 100.0% ee. Met.
比較例1(活性炭処理工程なし、種晶未使用)
ブリンゾラミド粗体(純度98.25%)1gにエタノール12gを加え70℃で加熱溶解して得られた第一溶液を、攪拌しながら徐冷し、0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃のエタノール0.8gで2回洗浄し、ブリンゾラミド結晶0.9g(純度99.51%)を得た。得られたブリンゾラミド結晶の融点は127℃であり、光学純度は99.9%ee.であった。
Comparative Example 1 (No activated carbon treatment process, seed crystal unused)
A first solution obtained by adding 12 g of ethanol to 1 g of brinzolamide crude product (purity 98.25%) and dissolving by heating at 70 ° C. was gradually cooled with stirring, cooled to 0 ° C., and stirred for 1 hour. The precipitated crystals were obtained by filtration and washed twice with 0.8 g of ethanol at 0 ° C. to obtain 0.9 g of brinzolamide crystals (purity 99.51%). The obtained brinzolamide crystals had a melting point of 127 ° C. and an optical purity of 99.9% ee. Met.
比較例2(種晶未使用)
ブリンゾラミド粗体(純度98.24%)15.07gにエタノール40gを加え70℃で加熱溶解して得られた第一溶液に、活性炭1.3g加え10分間攪拌した後、濾過操作によって活性炭を除去し、70℃のエタノール10gで活性炭を洗浄し、濾液と洗浄液を合わせて第二溶液を得た(活性炭処理工程)。第二溶液を攪拌しながら0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃のエタノール10gで2回洗浄し、ブリンゾラミド結晶12.83g(純度99.34%)を得た(結晶化工程1回目)。この結晶にエタノール45gを加え、70℃で加熱溶解した。0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃のエタノール9.5gで2回洗浄し、ブリンゾラミド結晶11.2g(純度99.57%)を得た(結晶化工程2回目)。この結晶にエタノール44gを加え、70℃で加熱溶解した。0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃のエタノール9gで2回洗浄し、ブリンゾラミド結晶10.7g(純度99.79%)を得た(結晶化工程3回目)。得られたブリンゾラミド結晶の融点は129℃であり、光学純度は99.9%ee.であった。
Comparative Example 2 (no seed crystals used)
After adding 40g of ethanol to 15.07g of brinzolamide crude body (purity 98.24%) and heating and dissolving at 70 ° C, 1.3g of activated carbon was added and stirred for 10 minutes, and then the activated carbon was removed by filtration. The activated carbon was washed with 10 g of ethanol at 70 ° C., and the filtrate and the washing solution were combined to obtain a second solution (activated carbon treatment step). The second solution was cooled to 0 ° C. with stirring and stirred for 1 hour. The precipitated crystals were obtained by filtration and washed twice with 10 g of ethanol at 0 ° C. to obtain 12.83 g of brinzolamide crystals (purity 99.34%) (first crystallization step). To this crystal, 45 g of ethanol was added and dissolved by heating at 70 ° C. It cooled to 0 degreeC and stirred for 1 hour. Precipitated crystals were obtained by filtration and washed twice with 9.5 g of ethanol at 0 ° C. to obtain 11.2 g of brinzolamide crystals (purity 99.57%) (the second crystallization step). 44 g of ethanol was added to the crystals and dissolved by heating at 70 ° C. It cooled to 0 degreeC and stirred for 1 hour. The precipitated crystals were obtained by filtration and washed twice with 9 g of ethanol at 0 ° C. to obtain 10.7 g of brinzolamide crystals (purity 99.79%) (the third crystallization step). The obtained brinzolamide crystal had a melting point of 129 ° C. and an optical purity of 99.9% ee. Met.
比較例3(活性炭処理工程なし)
ブリンゾラミド粗体(純度98.24%)12.49gにエタノール197gを加え70℃で加熱溶解して得られた第一溶液を、攪拌しながら50℃まで徐冷し、種晶0.012gを添加した後、100分間で0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃のエタノール9.9gで2回洗浄し、ブリンゾラミド結晶11.24g(純度98.46%)を得た(結晶化工程1回目)。この結晶にエタノール177gを加え、70℃で加熱溶解した。溶液を攪拌しながら50℃まで徐冷し、種晶0.011g添加した後100分間で0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃のエタノール8.9gで2回洗浄し、ブリンゾラミド結晶10.15g(純度99.25%)を得た(結晶化工程2回目)。この結晶にエタノール130gを加え、70℃で加熱溶解した。溶液を攪拌しながら50℃まで徐冷し、種晶0.010g添加した後100分間で0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃のエタノール8gで2回洗浄し、乾燥後、ブリンゾラミド結晶9.14g(純度99.39%)を得た(結晶化工程3回目)。得られたブリンゾラミド結晶の融点は128℃であり、光学純度は99.8%ee.であった。
Comparative Example 3 (no activated carbon treatment process)
The first solution obtained by adding 197 g of ethanol to 12.49 g of brinzolamide crude product (purity 98.24%) and heating and dissolving at 70 ° C. is gradually cooled to 50 ° C. with stirring, and 0.012 g of seed crystals is added. Then, it was cooled to 0 ° C. over 100 minutes and stirred for 1 hour. Precipitated crystals were obtained by filtration and washed twice with 9.9 g of ethanol at 0 ° C. to obtain 11.24 g (purity 98.46%) of brinzolamide crystals (first crystallization step). 177 g of ethanol was added to the crystals and dissolved by heating at 70 ° C. The solution was gradually cooled to 50 ° C. while stirring, 0.011 g of seed crystals were added, and then cooled to 0 ° C. over 100 minutes and stirred for 1 hour. The precipitated crystals were obtained by filtration and washed twice with 8.9 g of ethanol at 0 ° C. to obtain 10.15 g (purity 99.25%) of brinzolamide crystals (the second crystallization step). 130 g of ethanol was added to the crystals and dissolved by heating at 70 ° C. The solution was gradually cooled to 50 ° C. with stirring, 0.010 g of seed crystals were added, and then cooled to 0 ° C. over 100 minutes and stirred for 1 hour. Precipitated crystals were obtained by filtration, washed twice with 8 g of ethanol at 0 ° C., and dried to obtain 9.14 g of brinzolamide crystals (purity 99.39%) (the third crystallization step). The obtained brinzolamide crystal had a melting point of 128 ° C. and an optical purity of 99.8% ee. Met.
比較例4(活性炭処理工程なし、2−プロパノールによる結晶化工程)
ブリンゾラミド粗体(純度98.64%)17.12gに2−プロパノール135gを加え70℃で加熱溶解して得られた第一溶液を、攪拌しながら0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃の2−プロパノール14gで2回洗浄し、ブリンゾラミド結晶16.75g(純度98.95%)を得た(結晶化工程1回目)。この結晶に2−プロパノール107gを加え、70℃で加熱溶解した。溶液を攪拌しながら0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃の2−プロパノール11gで2回洗浄し、ブリンゾラミド結晶15.61g(純度99.02%)を得た(結晶化工程2回目)。この結晶に2−プロパノール98gを加え、70℃で加熱溶解した。溶液を攪拌しながら0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃の2−プロパノール12gで2回洗浄し、ブリンゾラミド結晶15.53g(純度99.21%)を得た(結晶化工程3回目)。得られたブリンゾラミド結晶の融点は125℃であり、光学純度は99.8%ee.であった。
Comparative Example 4 (No activated carbon treatment step, crystallization step with 2-propanol)
A first solution obtained by adding 135 g of 2-propanol to 17.12 g of a brinzolamide crude product (purity 98.64%) and heating and dissolving at 70 ° C. was cooled to 0 ° C. with stirring and stirred for 1 hour. The precipitated crystals were obtained by filtration and washed twice with 14 g of 2-propanol at 0 ° C. to obtain 16.75 g of brinzolamide crystals (purity 98.95%) (first crystallization step). To this crystal, 107 g of 2-propanol was added and dissolved by heating at 70 ° C. The solution was cooled to 0 ° C. with stirring and stirred for 1 hour. Precipitated crystals were obtained by filtration and washed twice with 11 g of 2-propanol at 0 ° C. to obtain 15.61 g of brinzolamide crystals (purity 99.02%) (the second crystallization step). 2-propanol 98g was added to this crystal | crystallization, and it heat-dissolved at 70 degreeC. The solution was cooled to 0 ° C. with stirring and stirred for 1 hour. The precipitated crystals were obtained by filtration and washed twice with 12 g of 2-propanol at 0 ° C. to obtain 15.53 g of brinzolamide crystals (purity 99.21%) (the third crystallization step). The obtained brinzolamide crystal had a melting point of 125 ° C. and an optical purity of 99.8% ee. Met.
比較例5(2−プロパノールによる結晶化工程)
ブリンゾラミド粗体(純度99.21%)15.53gに2−プロパノール100gを加え70℃で加熱溶解して得られた第一溶液に活性炭5g加え10分間攪拌した後、濾過操作によって活性炭を除去し、70℃の2−プロパノール20gで活性炭を洗浄し、濾液と洗浄液を合わせて第二溶液を得た(活性炭処理工程)。第二溶液を攪拌しながら0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃の2−プロパノール12gで2回洗浄し、ブリンゾラミド結晶10.19g(純度99.84%)を得た(結晶化工程1回目)。この結晶に2−プロパノール120gを加え、70℃で加熱溶解した。溶液を攪拌しながら0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃の2−プロパノール13gで2回洗浄し、ブリンゾラミド結晶8.09g(純度99.86%)を得た(結晶化工程2回目)。この結晶に2−プロパノール99gを加え、70℃で加熱溶解した。溶液を攪拌しながら0℃まで冷却して1時間攪拌した。析出結晶を濾過操作により取得し、0℃の2−プロパノール9gで2回洗浄し、ブリンゾラミド結晶7.44g(純度99.88%)を得た(結晶化工程3回目)。得られたブリンゾラミド結晶の融点は127℃であり、光学純度は99.9%ee.であった。
Comparative Example 5 (crystallization step with 2-propanol)
To the first solution obtained by adding 100 g of 2-propanol to 15.53 g of brinzolamide crude product (purity 99.21%) and heating and dissolving at 70 ° C. After adding 5 g of activated carbon and stirring for 10 minutes, the activated carbon was removed by filtration. The activated carbon was washed with 20 g of 2-propanol at 70 ° C., and the filtrate and the washing solution were combined to obtain a second solution (activated carbon treatment step). The second solution was cooled to 0 ° C. with stirring and stirred for 1 hour. The precipitated crystals were obtained by filtration and washed twice with 12 g of 2-propanol at 0 ° C. to obtain 10.19 g (purity 99.84%) of brinzolamide crystals (first crystallization step). To this crystal, 120 g of 2-propanol was added and dissolved by heating at 70 ° C. The solution was cooled to 0 ° C. with stirring and stirred for 1 hour. The precipitated crystals were obtained by filtration and washed twice with 13 g of 2-propanol at 0 ° C. to obtain 8.09 g of brinzolamide crystals (purity 99.86%) (the second crystallization step). 99 g of 2-propanol was added to the crystals and dissolved by heating at 70 ° C. The solution was cooled to 0 ° C. with stirring and stirred for 1 hour. The precipitated crystals were obtained by filtration and washed twice with 9 g of 2-propanol at 0 ° C. to obtain 7.44 g of brinzolamide crystals (purity 99.88%) (the third crystallization step). The obtained brinzolamide crystals had a melting point of 127 ° C. and an optical purity of 99.9% ee. Met.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012177972A JP5914246B2 (en) | 2012-08-10 | 2012-08-10 | Method for purifying brinzolamide |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012177972A JP5914246B2 (en) | 2012-08-10 | 2012-08-10 | Method for purifying brinzolamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014034566A JP2014034566A (en) | 2014-02-24 |
| JP5914246B2 true JP5914246B2 (en) | 2016-05-11 |
Family
ID=50283760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012177972A Expired - Fee Related JP5914246B2 (en) | 2012-08-10 | 2012-08-10 | Method for purifying brinzolamide |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5914246B2 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5153192A (en) * | 1990-04-09 | 1992-10-06 | Alcon Laboratories, Inc. | Thiophene sulfonamides useful as carbonic anhydrase inhibitors |
| JPH07291966A (en) * | 1994-04-26 | 1995-11-07 | Kissei Pharmaceut Co Ltd | Production of (5z)-6-((2s,4r)-4-(4-chlorophenyl-sulfonylamino)-1-(3-pyridylmethyl)-2-pyrrolidinyl)-5-hexenoic acid and synthetic intermediate thereof |
| JPH10306079A (en) * | 1997-03-05 | 1998-11-17 | Takeda Chem Ind Ltd | Crystal of azole-based compound |
| USH2154H1 (en) * | 2003-10-08 | 2006-04-04 | Farmak, A.S. | Process for preparing R- and S-isomers of (R)-5-(2-( (2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide |
| JP2008031042A (en) * | 2004-11-17 | 2008-02-14 | Eisai Co Ltd | Method for producing n-(3-chloro-1h-indol-7-yl)-4-sulfamoylbenzenesulfonamide |
-
2012
- 2012-08-10 JP JP2012177972A patent/JP5914246B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014034566A (en) | 2014-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020526476A (en) | Synthesis of Omekamtive Mecalville | |
| CN106632267A (en) | Method for synthesizing voriconazole | |
| TWI541235B (en) | Process of preparing a quinazoline derivative | |
| WO2018008219A1 (en) | Azilsartan intermediate, azilsartan, method for producing azilsartan intermediate, and method for producing azilsartan | |
| JP2022500433A (en) | Method for Producing Solid Form of BET Bromodomain Inhibitor | |
| JP5914246B2 (en) | Method for purifying brinzolamide | |
| JP2011006379A (en) | Method for recrystallizing {2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridine dicarboxylic acid-3-[1-(diphenylmethyl)azetidin-3-yl]ester-5-isopropyl ester}(azelnidipine), isopropyl alcohol adduct of azelnidipine, and method for producing azelnidipine | |
| WO2017131218A1 (en) | Azilsartan and method for producing same | |
| JP2008201740A (en) | Method for purifying edaravone and highly pure edaravone | |
| JP4545911B2 (en) | Method for producing camostat mesylate | |
| JP6091339B2 (en) | Method for producing olmesartan medoxomil | |
| JP6242298B2 (en) | 1- (3-Benzoyloxypropyl) -7-cyano-5-[(2R) -2-({2- [2- (2,2,2-trifluoroethoxy) phenoxy] ethyl} amino) propyl] indoline Or a method for producing the salt thereof | |
| JP5836851B2 (en) | Method for producing brinzolamide | |
| JP2012020970A (en) | Method for producing {3-(1-diphenylmethylazetidin-3-yl)ester-5-isopropyl ester 2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate} | |
| JP4849374B2 (en) | Method for preparing mixed crystals of (±)2-(dimethylamino)-1-{[O-(m-methoxyphenethyl)phenoxy]methyl}ethyl hydrogen succinate hydrochloride (I crystal form and II crystal form) | |
| JP6275596B2 (en) | Method for producing ammonium salt of telmisartan | |
| JP6711709B2 (en) | Method for producing ezetimibe | |
| JP6676491B2 (en) | Method for producing azilsartan alkyl ester and method for producing azilsartan | |
| WO2016071382A1 (en) | Synthesis of pi3k inhibitor and salts thereof | |
| JP6516576B2 (en) | Process for the preparation of (3R, 4S) -1- (4-fluorophenyl)-[3 (S) -hydroxy-3- (4-fluorophenyl) propyl]-[4- (phenylmethoxy) phenyl] -2-azetidinone | |
| JP6483483B2 (en) | Manufacturing method of ezetimibe | |
| JP6382660B2 (en) | Method for producing olmesartan medoxomil | |
| JP2019131532A (en) | Acid anhydride, and method for producing l-carnosine with the acid anhydride | |
| CN107652269A (en) | Methanesulfonic acid fluorine imatinib purification of intermediate method | |
| CN112778370A (en) | Method for preparing forrestituitan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150805 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160308 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160310 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160404 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5914246 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |
